SCHEMBL8339028

SCHEMBL8339028

CNC(=S)NC(=O)C(CCCN=S(=O)=O)c1ccc(C)cc1

nearest known ligand 0.33

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 1/20 0.33
▸ ALDH1A1 P00352 3/20 0.32
▸ KDM4E B2RXH2 2/20 0.32
▸ LMNA P02545 1/20 0.32
▸ MEN1 O00255 2/20 0.31
▸ KMT2A Q03164 2/20 0.31
▸ SMN1; SMN2 Q16637 2/20 0.31
▸ HTT P42858 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31
▸ CNR1 P21554 1/20 0.31
▸ CNR2 P34972 1/20 0.31
▸ CASP3 P42574 1/20 0.30
▸ NPC1 O15118 1/20 0.30
▸ ALOX12 P18054 1/20 0.30
▸ RAB9A P51151 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8338337 0.81 GAA (0.35) GAAALDH1A1KDM4ELMNAMEN1
SCHEMBL8338863 0.80 ALDH1A1 (0.35) GAAALDH1A1KDM4ELMNAMEN1
SCHEMBL8339611 0.80 — —
SCHEMBL8340341 0.79 KDM4E (0.36) GAAALDH1A1KDM4ELMNAMEN1
SCHEMBL8339878 0.79 ALDH1A1 (0.33) GAAALDH1A1KDM4ELMNAMEN1
SCHEMBL8333490 0.78 — —
SCHEMBL8333962 0.71 KDM4E (0.37) GAAALDH1A1KDM4ELMNAMEN1
SCHEMBL8340828 0.70 KDM4E (0.36) GAAALDH1A1KDM4ELMNAMEN1
SCHEMBL8340568 0.70 KDM4E (0.36) GAAALDH1A1KDM4ELMNAMEN1
SCHEMBL8337813 0.70 TDP1 (0.39) GAAALDH1A1KDM4ELMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5977177-A Substituted benzenesulfonylureas and-thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them HOECHST AKTIENGESELLSCHAFT (DE) 1999-11-02 — — US disclosed
US-5880155-A TREATMENT OF CARDIOVASCULAR DISORDERS HOECHST AKTIENGESELLSCHAFT (DE) 1999-03-09 — — US disclosed
Send feedback